The stock of Cardinal Health, Inc. (CAH) has gone up by 0.77% for the week, with a -7.81% drop in the past month and a -6.44% drop in the past quarter. The volatility ratio for the week is 1.81%, and the volatility levels for the past 30 days are 1.99% for CAH. The simple moving average for the past 20 days is 0.12% for CAH’s stock, with a -5.74% simple moving average for the past 200 days.
Is It Worth Investing in Cardinal Health, Inc. (NYSE: CAH) Right Now?
The price-to-earnings ratio for Cardinal Health, Inc. (NYSE: CAH) is above average at 42.87x, Company’s 36-month beta value is 0.62.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 15 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CAH is 242.13M, and currently, short sellers hold a 2.53% ratio of that floaft. The average trading volume of CAH on July 25, 2024 was 2.04M shares.
CAH) stock’s latest price update
The stock price of Cardinal Health, Inc. (NYSE: CAH) has surged by 0.91 when compared to previous closing price of 95.84, but the company has seen a 0.77% gain in its stock price over the last five trading sessions. zacks.com reported 2024-07-24 that In the most recent trading session, Cardinal Health (CAH) closed at $96.71, indicating a +0.91% shift from the previous trading day.
Analysts’ Opinion of CAH
Many brokerage firms have already submitted their reports for CAH stocks, with Leerink Partners repeating the rating for CAH by listing it as a “Outperform.” The predicted price for CAH in the upcoming period, according to Leerink Partners is $125 based on the research report published on February 26, 2024 of the current year 2024.
Barclays gave a rating of “Overweight” to CAH, setting the target price at $117 in the report published on January 03rd of the current year.
CAH Trading at -1.37% from the 50-Day Moving Average
After a stumble in the market that brought CAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.66% of loss for the given period.
Volatility was left at 1.99%, however, over the last 30 days, the volatility rate increased by 1.81%, as shares sank -6.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.83% lower at present.
During the last 5 trading sessions, CAH rose by +0.77%, which changed the moving average for the period of 200-days by +7.67% in comparison to the 20-day moving average, which settled at $96.27. In addition, Cardinal Health, Inc. saw -4.06% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CAH starting from WEITZMAN DEBORAH, who sale 36,642 shares at the price of $106.31 back on Nov 27 ’23. After this action, WEITZMAN DEBORAH now owns 35,202 shares of Cardinal Health, Inc., valued at $3,895,411 using the latest closing price.
WEITZMAN DEBORAH, the CEO, Pharmaceutical Segment of Cardinal Health, Inc., sale 6,712 shares at $89.81 during a trade that took place back on Aug 28 ’23, which means that WEITZMAN DEBORAH is holding 44,202 shares at $602,805 based on the most recent closing price.
Stock Fundamentals for CAH
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.03 for the gross margin
The net margin for Cardinal Health, Inc. stands at 0.0. The total capital return value is set at 0.13.
Based on Cardinal Health, Inc. (CAH), the company’s capital structure generated 2.26 points at debt to capital in total, while cash flow to debt ratio is standing at 0.43. The debt to equity ratio resting at -1.79. The interest coverage ratio of the stock is 17.23.
Currently, EBITDA for the company is 2.47 billion with net debt to EBITDA at 0.76. When we switch over and look at the enterprise to sales, we see a ratio of 0.12. The receivables turnover for the company is 19.07for trailing twelve months and the total asset turnover is 4.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.98.
Conclusion
In a nutshell, Cardinal Health, Inc. (CAH) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
